ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 324 filers reported holding ARRAY BIOPHARMA INC in Q2 2019. The put-call ratio across all filers is 1.86 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $27,469,000 | +572.8% | 592,903 | +254.0% | 0.03% | +550.0% |
| Q1 2019 | $4,083,000 | +68.5% | 167,494 | -2.1% | 0.00% | +33.3% |
| Q4 2018 | $2,423,000 | -8.8% | 171,034 | -2.1% | 0.00% | +50.0% |
| Q3 2018 | $2,656,000 | -50.3% | 174,725 | -45.2% | 0.00% | -60.0% |
| Q2 2018 | $5,349,000 | -9.0% | 318,770 | -11.5% | 0.01% | -16.7% |
| Q1 2018 | $5,876,000 | +17.7% | 360,015 | -7.7% | 0.01% | +50.0% |
| Q4 2017 | $4,992,000 | +7.7% | 389,985 | +3.4% | 0.00% | 0.0% |
| Q3 2017 | $4,637,000 | +330.5% | 377,000 | +59.6% | 0.00% | +300.0% |
| Q2 2014 | $1,077,000 | -3.6% | 236,277 | -0.6% | 0.00% | 0.0% |
| Q1 2014 | $1,117,000 | -11.6% | 237,602 | -5.7% | 0.00% | -50.0% |
| Q4 2013 | $1,263,000 | -24.0% | 252,031 | -5.6% | 0.00% | 0.0% |
| Q3 2013 | $1,661,000 | – | 267,060 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 16,618,776 | $146,079,000 | 12.59% |
| BVF INC/IL | 4,986,186 | $43,829,000 | 8.81% |
| First Light Asset Management, LLC | 1,000,361 | $8,793,000 | 3.86% |
| Crosspoint Capital Strategies, LLC | 463,005 | $4,070,000 | 3.62% |
| Consonance Capital Management LP | 2,723,471 | $23,912,000 | 2.63% |
| KOPP INVESTMENT ADVISORS LLC | 219,926 | $1,933,000 | 2.04% |
| SPHERA FUNDS MANAGEMENT LTD. | 900,000 | $7,911,000 | 2.00% |
| Orbimed Advisors | 16,088,800 | $141,421,000 | 1.80% |
| Cormorant Asset Management, LP | 1,150,000 | $10,109,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,073,680 | $18,227,000 | 1.26% |